Partnering Hall Speakers Agenda Overview WSGR website
2018 Conference Agenda

Thursday June 21, 2018
Sharon Heights Golf and Country Club
2900 Sand Hill Road
Menlo Park, CA

6:00 – 9:00 p.m.

Dinner Discussion – How Hospital Buying Practices Impact New Product Adoption
Today, hospital systems are wielding unprecedented power and influence in decision-making about the products they buy. The days are gone when medtech companies with a compelling new technology could ensure success simply by demonstrating better treatment outcomes. In this session, LEK, a leading healthcare consulting firm, will share insights on how hospital system buying practices are changing, and what young medtech companies need to build market traction..

Friday June 22, 2018

Palace Hotel
2 New Montgomery Street
San Francisco, CA

7:00 – 8:00 a.m.

Conference Registration and Continental Breakfast

8:00 – 8:10 a.m.

Welcome – Casey McGlynn, Wilson Sonsini Goodrich & Rosati

8:10 – 9:10 a.m.

Medtech Venture Capital – State of the Industry
Getting a new medical device company funded is more difficult today. An ever-shrinking pool of investors interested in early-stage life sciences investing, more stringent capital requirements due to prolonged regulatory and reimbursement timelines, and the need for true sales traction to garner the attention of potential corporate acquirers have all become hallmarks of the current financing environment. How are investors adapting their financing strategies and business models to accommodate these realities and positioning themselves for long-term success? Join a panel of medtech investors as they discuss their approaches to investing in these changing times.

9:10 – 9:30 a.m.


9:30 – 10:30 a.m.

Breakout Session 1

Evolving World of Incubators
The way we organize, fund, and build medtech companies has changed radically over the last decade. Join a panel of experienced executives and entrepreneurs to learn about the new emerging models for innovation. Learn about the methods others are using to identify important new innovations, rapidly build product prototypes, and complete early first-in-man cases all in a more intelligent and cost effective manner.

AI in Medtech
The adoption of artificial intelligence in healthcare is on the rise and solving a variety of problems today for patients, hospitals, and the healthcare industry overall. This panel will take a closer look at how AI is solving problems in healthcare today and what’s on the horizon for the healthcare industry in the next five years. Join this panel of AI healthcare CEOs to learn how their companies are changing the world of healthcare.

FDA Panel: Design Controls – Best Practices
For medical device manufacturers, avoiding product recalls, FDA enforcement action, and product liability exposure starts with robust design controls: design process, hazard analysis documentation, and testing. Quality practices are built up-front and not tested after production. This panel of industry experts will discuss the elements for design control and the dire consequences of failing to implement a robust system of design controls.

10:30 – 10:50 a.m.


10:50 – 11:50 a.m.

Breakout Session 2

China Funding Strategies
During the last several years China’s investment interest in U.S. medtech has grown significantly. These transactions take many forms – loans, preferred stock, license arrangements, and joint ventures. Join a panel of experienced CEOs as they describe transactions they have completed with Chinese investors. Learn how these transactions are structured, how companies overcome restrictions on outbound investments, and the factors that draw Chinese investors to the U.S. and U.S. entrepreneurs to China.

Hiring and Compensating the CEO
Join a group of compensation experts as they look at recent trends and emerging best practices in medtech executive compensation. Participate in a discussion of current salary, as well as stock and bonus structures for management. Learn about the structure and pitfalls associated with carve-out plans and innovative ways to provide management teams compensation for successful exits. Finally, learn what executive recruiters are looking for in a resume and how networking skills can help you land your next great job.

Workplace Sexual Harassment – Is Your Organization Prepared?
It seems like every day a new name or organization is added to the growing list of those facing a sexual harassment allegation. But what about your organization? Are you confident your managers and employees are properly trained to avoid becoming one of the headlines? Do you know the steps to take if an employee comes to you with a sexual harassment claim? It’s crucial to have the answers to these questions and many more so you can keep your organization safe and in compliance.

11:50 a.m. – 12:10 p.m.


12:10 – 1:10 p.m.

Breakout Session 3

Mergers & Acquisitions
M&A activity in the medtech sector continues at a solid pace. Medtech consolidators have been busy exercising buyout options they put in place in prior years, while a growing number of Medtech companies have completed mergers on the eve of regulatory approval or soon after launching their products in the United States. Against this backdrop, our panel will explore recent M&A transactions with the goal of understanding what a company needs to have in place to successfully complete these transactions.

Collaborations Between Japan and Silicon Valley
It has been more than five years since Japan began its big push to grow their medical device industry. As more deals have been done, there has been increasing comfort by both sides in making deals. The results are investments, mergers, acquisitions, development projects, distribution agreements, etc. This represents a major opportunity for start-ups, in Silicon Valley and elsewhere, to seek investments from and partnerships with Japanese companies. Join this panel to learn about the ways in which Japan is collaborating to finance and develop advanced medical technologies.

All Razor with No Blades?
There has been a recent surge in the development of non-invasive, capital-intensive therapies addressing huge unmet needs. While these companies promise great clinical improvements, it is unclear whether these companies will be commercial successes. Their large upfront prices will be difficult for hospitals to finance and company revenues will be lumpy and unpredictable. This panel will discuss alternative pricing models to ensure success.

  • Have you encountered difficulties raising money due to the capital-intensive nature of your technologies?
  • How do you plan to price your technologies? What is the likely payback period at that price?
  • Have you considered only renting the technology?
  • Have you considered instituting "per click" pricing in addition to, or in place of, capital equipment pricing?

1:10 – 2:20 p.m.

Lunch Discussion, The Neotract Story

2:20 – 2:40 p.m.


2:40 – 3:40 p.m.

Breakout Session 4

Funding Strategies for Entrepreneurs
Finding capital today is difficult, no matter the stage of the company. This panel of entrepreneurs and CEOs will share their experiences in the search for capital. Learn about the methods and strategies these medtech leaders used to secure the capital they needed to move their projects forward.

Big Medtech’s Evolving Business Development Strategies
The Medtech consolidators have a challenge —they need to introduce important new products to grow their business, but internal innovation is both expensive and unpredictable. As a result they are increasingly looking externally to fill their pipelines. Companies that develop these products are well positioned to be rewarded, but they need to understand what the consolidators are looking for. Increasingly, they are turning to novel deal structures that can benefit both buyer and seller. Join a panel of business development executives to explore these issues.

Patents: The Role of IP Due Diligence in an Acquisition
Patent diligence is an inevitable part of an acquisition. For young companies, preparation is essential to present a positive picture to acquirers and avoid misunderstandings that can kill a deal or result in a major reduction in the purchase price. For buyers, having a realistic perspective on the practical value of patent protection and the true risks of third party patents is equally important. This panel will describe efficient approaches to diligence and practical ways for dealing with perceived risks which arise during the diligence process.

3:40 – 4:00 p.m.


4:00 – 5:00 p.m.

MedTech Innovator 2018
Four early-stage medtech companies selected from nearly 600 applications will present their pitches to a panel of judges. The judges will evaluate the presentations and provide feedback to each company. Ultimately, the audience votes for the winner of the $25K MedTech Innovator 2018 Value Award. The winner will also be profiled in an upcoming issue of The MedTech Strategist.

5:00 – 6:30 p.m.

Venture Capital Uncorked: Wine Tasting Reception
Join Wilson Sonsini Goodrich & Rosati for a wine tasting session following the conference. We will be sampling wines from various wineries, with venture capitalists serving as your sommeliers for the event. This is your chance to try some great wine and learn more about what each of our local venture firms is looking for in their next deal. It's a great pairing – wine with a venture capital twist.